Collegium Pharmaceutical, Inc. (COLL)
23.78
-0.52
(-2.14%)
USD |
NASDAQ |
Sep 03, 12:54
Collegium Pharmaceutical Net Income (Annual) : 62.87M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 62.87M |
| December 31, 2024 | 69.19M |
| December 31, 2023 | 48.16M |
| December 31, 2022 | -25.00M |
| December 31, 2021 | 71.52M |
| December 31, 2020 | 26.75M |
| December 31, 2019 | -22.72M |
| Date | Value |
|---|---|
| December 31, 2018 | -39.13M |
| December 31, 2017 | -74.86M |
| December 31, 2016 | -94.18M |
| December 31, 2015 | -27.26M |
| December 31, 2014 | -17.92M |
| December 31, 2013 | -3.958M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Innoviva, Inc. | 271.16M |
| Zevra Therapeutics, Inc. | 77.58M |
| Supernus Pharmaceuticals, Inc. | -38.55M |
| Indivior Pharmaceuticals, Inc. | 210.00M |
| Crinetics Pharmaceuticals, Inc. | -465.32M |